Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: A multicenter cross-sectional study

Archives of Dermatology

Volumn 147, Issue 4, 2011, Pages 391-398

  Hamaguchi, Yasuhito ^a   Kuwana, Masataka ^b   Hoshino, Kana ^b   Hasegawa, Minoru ^a   Kaji, Kenzo ^a   Matsushita, Takashi ^a   Komura, Kazuhiro ^a   Nakamura, Motonobu ^c   Kodera, Masanari ^d   Suga, Norihiro ^e   Higashi, Akira ^f   Ogusu, Koji ^g   Tsutsui, Kiyohiro ^h   Furusaki, Akira ⁱ   Tanabe, Hiroshi ^j   Sasaoka, Shunsuke ^k   Muro, Yoshinao ^l   Yoshikawa, Mika ^m   Ishiguro, Naoko ⁿ   Ayano, Masahiro ^o   Muroi, Eiji ^p   Fujikawa, Keita ^p   Umeda, Yukihiro ^q   Kawase, Masaaki ^r   Mabuchi, Eriko ^s   Asano, Yoshihide ^t   Sodemoto, Kinuyo ^u   Seishima, Mariko ^v   Yamada, Hidehiro ^w   Sato, Shinichi ^t   Takehara, Kazuhiko ^a   Fujimoto, Manabu ^a   more..

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d CHUKYO HOSPITAL   (Japan)

^e AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOYAMA RED CROSS HOSPITAL   (Japan)

^g Department of Dermatology   (Japan)

^h ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

ⁱ Sapporo Social Insurance Gen Hosp   (Japan)

^j KANAZAWA MEDICAL UNIVERSITY   (Japan)

^k KAWASAKI MEDICAL SCHOOL   (Japan)

^l NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^o KURASHIKI CENTRAL HOSPITAL   (Japan)

^p NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^q UNIVERSITY OF FUKUI   (Japan)

^r JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^s OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^t UNIVERSITY OF TOKYO   (Japan)

^u Kanto Teishin Hospital   (Japan)

^v OGAKI MUNICIPAL HOSPITAL   (Japan)

^w ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

155 140 ANTIBODY; AUTOANTIBODY; CADM 140 ANTIBODY; MI 2 ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CORRELATIONAL STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEROPREVALENCE; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; DERMATOMYOSITIS; FEMALE; GLUCOCORTICOIDS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISOLONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79953837289     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.52     Document Type: Article

References (44)

1. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. NIH conference: myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med. 1995;122(9):715-724.
2. Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol. 1993;100(1):116S-123S.
3. Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 1992;35(4):449-456.
4. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990;33(9):1361-1370. (Pubitemid 20365567)
5. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985;28(7):796-803. (Pubitemid 15027334)
6. Yamasaki Y, Yamada H, Nozaki T, et al. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum. 2006;54(6):2004-2009. (Pubitemid 43877951)
7. Matsushita T, Hasegawa M, Fujimoto M, et al. Clinical evaluation of antiaminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol. 2007;34(5):1012-1018. (Pubitemid 46774847)
8. Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signalrecognition particle. Proc Natl Acad Sci U S A. 1986;83(24):9507-9511. (Pubitemid 17223389)
9. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum. 2004;50(1):209-215. (Pubitemid 38084306)
10. Suzuki S, Satoh T, Sato S, et al. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford). 2008;47(10):1539-1542.
11. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991;70(6):360-374.
12. Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, Genth E. Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR β chain. Arthritis Rheum. 1996;39(5):868-876. (Pubitemid 26140434)
13. Komura K, Fujimoto M, Matsushita T, et al. Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis. J Dermatol Sci. 2005;40(3):215-217. (Pubitemid 41728971)
14. Reveille JD, Fischbach M, McNearney T, et al; GENISOS Study Group. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum. 2001;30(5):332-346. (Pubitemid 32298859)
15. Kaji K, Fujimoto M, Hasegawa M, et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 2007;46(1):25-28. (Pubitemid 44932779)
16. Targoff IN, Mamyrova G, Trieu EP, et al; Childhood Myositis Heterogeneity Study Group; International Myositis Collaborative Study Group. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006;54(11):3682-3689.
17. Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52(5):1571-1576. (Pubitemid 40663949)
18. Targoff IN, Trieu EP, Levy-Neto M, Prasertsuntarsai T, Miller FW. Autoantibodies to transcriptional intermediary factor 1-γ (TIF1-γ) in dermatomyositis. Arthritis Rheum. 2006;54(suppl):S518.
19. Sato S, Hoshino K, Satoh T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;60(7):2193-2200.
20. Gunawardena H, Wedderburn LR, North J, et al; Juvenile Dermatomyositis Research Group UK. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford). 2008;47(3):324-328. (Pubitemid 351267200)
21. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-347.
22. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403-407.
23. Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol. 1999;11(6):475-482. (Pubitemid 29506173)
24. Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46(4):626-636.
25. Fujikawa K, Kawakami A, Kaji K, et al. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol. 2009;38(4):263-267.
26. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271-1277.
27. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23(5):581-590.
28. Gunawardena H, Wedderburn LR, Chinoy H, et al; Juvenile Dermatomyositis Research Group, UK and Ireland. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum. 2009;60(6):1807-1814.
29. Bandoh S, Fujita J, Ohtsuki Y, et al. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/ dermatomyositis. Ann Rheum Dis. 2000;59(4):257-262. (Pubitemid 30305566)
30. Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford). 2009;48(6):607-612.
31. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 1994;37(1):75-83. (Pubitemid 24027696)
32. Fardet L, Dupuy A, Gain M, et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore). 2009;88(2):91-97.
33. Huang YL, Chen YJ, Lin MW, et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol. 2009;161(4):854-860.
34. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis. 2007;66(10):1345-1349. (Pubitemid 47492479)
35. Morganroth PA, Kreider ME, Okawa J, Taylor L, Werth VP. Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. Arch Dermatol. 2010;146(7):729-738.
36. Bendewald MJ, Wetter DA, Li X, Davis MD. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010;146(1):26-30.
37. Sontheimer RD. Clinically amyopathic dermatomyositis: what can we now tell our patients? Arch Dermatol. 2010;146(1):76-80.
38. Lee CS, Chen TL, Tzen CY, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol. 2002;21(5):391-396.
39. Ye S, Chen XX, Lu XY, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol. 2007;26(10):1647-1654.
40. Wong SS, Yuen KY. The severe acute respiratory syndrome (SARS). J Neurovirol. 2005;11(5):455-468. (Pubitemid 43064685)
41. Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2000;12(6):501-508.
42. Santiago MB, Chalhoub M, Pereira ST. Amyopathic dermatomyositis complicated by interstitial pulmonary disease and pneumomediastinum. J Rheumatol. 1998;25(10):2042-2043.
43. Yamanishi Y, Maeda H, Konishi F, et al. Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum. Scand J Rheumatol. 1999;28(1):58-61. (Pubitemid 29125231)
44. Yamasaki Y, Yamada H, Yamasaki M, et al. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Rheumatology (Oxford). 2007;46(1):124-130. (Pubitemid 44932799)